Cynata Therapeutics (ASX:CYP) Presentation, FNN Investor Event, March 2020, Sydney

Company Presentations

Cynata Therapeutics Limited (ASX:CYP) Managing Director Dr Ross MacDonald presents on 1H20 results, upcoming Phase 2 clinical trials, licensing and strategy to build the company's Cymerus cell therapy platform at FNN's Investor Event.

Investment highlights:

  • Outstandingly well-positioned in regenerative medicine.
  • Scalable, globally applicable technology.
  • Successful clinical trial results: world leader.
  • Attractive and validated licensing business model.
  • Clear pipeline of high potential target areas.

For more information, watch the presentation with Managing Director Dr Ross MacDonald.